It seems so easy to purchase stocks. Everyone else seems to be doing so. However, there must be careful investigations of diverse stocks on show. Some are clearly on the way out. Others are down now, but not on the way out! If you are new to crypto trading, read about how can a beginner start trading with crypto.
Guidelines for Selecting Stocks
True, the choice is vast, as evinced by the lengthy lists displayed on Nasdaq and the New York Stock Exchange. The CAN SLIM system offered by IBD, might provide some clues to wise choices!
The system suggests going after stocks, which have displayed at least a growth rate of 25% in their quarterly and annual reports. Probably, they have been able to stay on top by offering game-changing services/products. Then again, some companies had thus far, not shown much in the way of profits. However, they are displaying tremendous potential for progress now.
The CAN SLIM Investing System is excellent at performing beyond the S&P 500 index. Other guidelines, include – keeping track of demand and supply, going after stocks with excellent institutional support, and waiting for the perfect buy point.
Three Major Stocks to Purchase
Chevron
Based in California, Chevron is a natural gas and oil company. Chevron decided to focus on building up the Permian Basin. After all, prices were on the hike, and even supplies were dwindling, unable to match demand. The Permian Basin covers the largest production area in the US.
Chevron has an unconventional method of oil production. As a result of its concentrated efforts, the Permian Basin yielded 692,000 barrels of oil each day. This continued throughout the first quarter of 2022. Soon enough, it increased the number of barrels to something between 700,000 and 750,000 per day. Chevron has this dream of taking the output to over a million barrels per day, by 2025.
True, oil prices are on the rise. However, Chevron refuses to overflood the market with easily-available oil. It is happy that its stock still carries a rating of 97%. It is a relatively strong rating. From a flat base, it has reached a buy point of 174.76.
Something else of significance is the ownership of the current funds or mutual funds. By March 2022, there were 2,850 funds in ownership of the company’s stock, a significant leap from the previous quarter’s 2,774.
Merck
It is displaying a relative strength line, which is amazingly at a 16-month high. It is possible to purchase the stock at 89.58, which is the buy point.
- The IBD Composite Rating is excellent, standing at 97.
- With reputed people showing a keen interest in the company’s stocks, its Accumulation Distribution Rating has gone up to an astounding A-.
- The EPS rating is 93/99. Even the stock has gone beyond 26% during the last 12 months.
- Merck’s biggest draw is Keytruda, a treatment for cancer. This treatment brought in a revenue beyond 23%, around $4.8 billion. As Keytruda’s sales went beyond 27%, Gardasil’s sales also went beyond $1.5 billion. Gardasil is the vaccine for the human papillomavirus vaccine. Its sales rose beyond 60%.
- Then again, there is Lagevrio. It refers to the COVID-19 treatment sponsored by partners, Ridgeback and Biotherapeutics. Thus far, the sales graph has displayed a healthy 19% sales growth. Merck hopes to generate at least $5-$5.5 billion in sales.
Anthem
Anthem is a health insurance company. Breaking its ‘downward trend’ jinx, it has managed to bring its flat base to a buy point of 533.78.
- Several factors suggest that it is good stock to purchase. Log on to Bitcoin smart for crypto trading, an official website that simplified trading.
- By mid-May, the company had undercut the key level, and is almost at that 50-day moving average.
- The relative strength line is gloriously high, as tracked by S&P 500.S&P 500 is a key gauge of any stock’s performance.
- Its all-round performance rating (Composite Rating) is 97.
- Anthem’s stocks have gone up by 12%. In other words, the performances in both arenas – stock market, and earnings, are impressive!
- The company is also going in for a change in name. Anthem will become Elevance Health in June, A new ticket, ELV, will also come into being for trading activities in that month.
Finally, Anthem oversees Blue Cross Blue Shield plans. They operate in several states, simultaneously. Investors may expect good returns from this field, when stock prices and interest rates go up.